Missouri Senate Bill SB1103

Missouri 2022 Regular Session

• Introduced: 1/27/22
• Refer: 3/7/22

Caption

Prohibits public financial benefits to abortion facilities and their affiliates or associates

Impact

This bill could significantly alter the landscape of funding for abortion facilities, effectively cutting off public financial support and enforcing strict conditions on any pre-existing benefits. The intent is to redirect public funds away from abortion services, impacting accessibility to reproductive health services in Missouri. The legal ramifications of non-compliance could result in forfeiture of benefits and further legal actions to reclaim funds. The notion is to create a permeating restriction that extends beyond the immediate financial benefits, affecting any potential future developments or funding allocations.

Summary

Senate Bill 1103 aims to prohibit public financial benefits to abortion facilities and their affiliates or associates in Missouri. This legislation intends to amend chapter 188 of the Revised Statutes of Missouri by adding section 188.212, which outlines the restrictions on any economic or financial assistance provided by the state or its political subdivisions to such facilities. Under the proposed bill, projects related to existing or new abortion facilities will not be eligible for any form of public financial assistance starting from August 28, 2022. Additionally, properties that have previously received public financial benefits cannot be used for abortion-related purposes in perpetuity.

Contention

There may be notable points of contention surrounding this bill, particularly in the context of reproductive rights and local governmental powers. Supporters argue that this measure reinforces the state's commitment to restrict abortion services and aligns public funding with their ethical stance on abortion. Conversely, opponents may view this as an overextension of government intervention into healthcare and a restriction on women's access to necessary health services. The bill also raises concerns about potential negative implications for related healthcare services that may indirectly benefit from public funds.